Prot# P05685: A Phase 3 Safety and Efficacy Study of Boceprevir in Combination with Peginterferon Alfa-2a and Ribavirin in Subject with Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment with Peginterferon/Ribavirin

Project: Research project

Project Details

StatusFinished
Effective start/end date3/25/093/24/12

Funding

  • Schering-Plough Corporation (P05685)